Andy Pasternak, EVP and Chief Business Officer at Horizon Therapeutics Public Ltd Co (HZNP), sold 46,500 shares at $107.83 ($5.0M) on 2021-09-09, disclosed to the SEC on 2021-09-13.
Open-market sale of $5.0M HZNP by EVP and Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $107.83 | 22,754 | $2.5M | 48.9% |
| 2 | $107.83 | 22,754 | $2.5M | 48.9% |
| 3 | $108.26 | 496 | $54K | 1.1% |
| 4 | $108.26 | 496 | $54K | 1.1% |
| Total | $107.84 avg | 46,500 | $5.0M | 100% |
| Filing → |
| HZNP | SELL | 2022-07-29 | $801K | — | Filing → |
| HZNP | SELL | 2022-06-13 | $130K | — | Filing → |
| HZNP | SELL | 2022-02-18 | $249K | — | Filing → |